Member Info for Investor_Bill

Certainly unusual given recent volume.

I think I heard this right after playing it back..... Interesting that he knows the CEO of EA listens to the podcast - 20mins 06 seconds in.

Added to my position today on the drop and averaged down. I think there's a way to go yet but it seems good value at this level.

Also, if sorted by best sellers (Link below), we're climbing up the list slowly as we were second page when I looked the other day. Even the supposed best selling oil only has one review. Early days yet but only morons could duck this up... oh wait... hang on, shucks.... Joking aside, I'm happy with my investment at the mo and it won't have to rise much before I'm blue.

https://leafyquick.com/collections/cbd-oil?sort_by=best-selling

Nice to see things are moving forward but...... Would someone pass me the jam, today or tomorrow will do.

Read the rns. None sold...

Other (please specify)iii:
No trading in the stock - voting control interest over stock transferred to new manager.

A year ago today we closed at 71 following days were 86 & 101. Nothing fundamentally has changed in the intervening 12 months, if anything the underlying position of the company has improved. Not necessarily to those highs but I certainly believe the SP should be double it's current level. It's the sentiment that's gone. Partly through lack of updates & communication but also with people getting bored and chasing rainbows elsewhere. I'm here for the long run and still believe that news will come, just a matter of when. There's few people that can be showing a profit selling at these levels so sit tight, that's my advice.

Getting quoted 1.2001 to sell 100k at the mo... Something brewing I'm sure.

I'm rather hoping the delay is due to more than one interested party. A universal flu vaccine, who wouldn't want to be part of that pie.

Not sure I remember it being as low as 18 before. I first bought in at 19 last April. Sold some near the top bought a few on the way down and then been more sub 30s. I'm guessing talks must be ongoing. No news (although frustrating) is good news I'd think. Flu-V isn't our only iron in the fire either. The Pharma world moves slowly but as has been said before, news, when it does come, will likely be out of the blue. I don't intend to sell a bean and will top up more if and when funds allow. - Like you say, at this level nothing is priced in.

Oh and if you're sitting on the sidelines I'd buy a few so you've got a foot in the door. Any whiff of news and you'll find it hard to get in at anywhere near these levels. - All IMO - DYOR etc.

Tight spread then as was getting .20 to sell before your purchase. Glad I topped up at 18.25 the other day. I feel it in my bones that news is imminent!

Zoetic: is a Greek word which refers to a person who touches on the very essence of the human experience....

My human experience would be improved greatly if this share price moves it's arse and catches up with where it should be!

That was a quick in out trade... Not bad for 40mins!

That's what I was thinking but they're good prices if sells. If they were then I'd have thought we'd have seen quite a dramatic decrease in the sp. Like you say, hard to determine.

Blimey those are some large chunks changing hands this morning. Doesn't appear to have shift sp either way. Anyone care to elaborate?

The 540k was a buy..... I'm guessing the other two at 500k were too. But you're right it's still sliding without news. Hopefully not long now though. We know the technology is good, they just need to sell it!

BigDish is a brand-new way of offering dining deals and discounts. Through its online reservation platform, diners can enjoy discounts of up to 50% at incredible restaurants throughout the UK.

With BigDish, there is no more need to wait for the right deal, or to print coupons, or to pay an expensive yearly membership fee. Reservations with discounts can be made at any hour of the day with an absolute minimal effort - 100% free of charge. All you need to do is download our app (available for iOS and Android) or use our website, select your restaurant, and make a reservation. Reservations are instantly confirmed. Even the best restaurants have empty tables, and we are more than happy to connect these with hungry diners.

BigDish understands that food is a universal language: whether you’re out to celebrate, trying to impress a date, or unwinding with your mates, we’ll be there to make your dining experience even better.

'THROUGHOUT THE UK' ..... It's only a matter of time and I don't think it'll be long in coming.

This is AIM... There are no morals!!! - It's ok, I'm a mere mortal too

Any ideas why it's up 3.51% with 12,492,075 sold vs 2,250,817 bought?

You're right Leas, with a current market cap of £28m the company is undervalued regardless of Flu-V. The trouble with AIM is people chasing rainbows. We've all done it, myself included. Flu-V can indeed just go to P3 but if we proceed before NIH confirmation we'd be going down that path alone. Trevor was however confident that should that be the case it would be done with non-dilutive funding. IMO with independent confirmation it's a different ball game. Long term and with hopefully a return to profitability in 2019 I'm confident this will come good. Any deals on the side will just be a bonus.

As for CEO replacement, not as far as I know yet. There will be an RNS of any new appointment I would think.

The way I see it goes back to the RNS of March 26th this year....

"Kym Denny, CEO of hVIVO, commented:Â

"While we note the preliminary determination that the primary endpoint only trended to statistical significance, we are mindful of the prespecified additional analysis being conducted by the NIH, that may have an impact, before opining conclusively. That said, the symptom reduction data we have seen in this study with FLU-v is incredibly exciting and consistent with this universal flu vaccine candidate's putative mechanism of action. In the real world, ultimately, it is symptom reduction that is a clinically meaningful outcome if it can reduce the more severe flu disease, which is the concern and significant burden of healthcare systems across the world. This is, to our knowledge, the first time a universal flu vaccine candidate has demonstrated statistically significant reduction in a symptom score in humans. As a result, we believe FLU-v could be the most advanced universal flu vaccine candidate in development. With its potential for significant disease efficacy, broad protection against all flu strains, simplified manufacturing and the ability to be administered as a stand-alone vaccine - rather than in combination with traditional seasonal flu vaccine - FLU-v could help provide relief from flu to people across the globe."

In particular - "we are mindful of the prespecified additional analysis being conducted by the NIH, that may have an impact, before opining conclusively."

We are still awaiting NIH conformation and as our trial was conducted by ourselves with our own vaccine any potential investor would surely want an independent verification before singing a deal. Hvivo isn't in control of when this confirmation will land. It could be (and wouldn't it be nice) that a deal has already been lined up if the NIH results confirm our own. The results could land tomorrow or it could be weeks/months away but my guess is that there won't be any progress with Flu-v until this confirmation lands.

All in my opinion of course and don't mind being corrected if I'm way off the mark. DYOR

Time frame? ......... Between 24 hours & 2 years, roughly.